| 1. Executive Summary |
| 2. Global Breast Cancer Screening Market Introduction |
| 2.1. Global Breast Cancer Screening Market – Taxonomy |
| 2.2. Global Breast Cancer Screening Market –Definitions |
| 2.2.1. Component |
| 2.2.2. Technology |
| 2.2.3. Application |
| 2.2.4. End User |
| 2.2.5. By Region |
| 3. Global Breast Cancer Screening Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Breast Cancer Screening Market Dynamic Factors - Impact Analysis |
| 3.6. Global Breast Cancer Screening Market – Competition Landscape |
| 3.7. Epidemiology |
| 4. Global Breast Cancer Screening Market Analysis, 2017-2021 and Forecast, 2022-2028 |
| 4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Breast Cancer Screening Market, By Component, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.1. Reagents and Kits |
| 5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Instruments |
| 5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Software and Services |
| 5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6. Global Breast Cancer Screening Market, By Technology, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 6.1. Imaging |
| 6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Biopsy |
| 6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Genomic Tests |
| 6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Blood Tests |
| 6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Others |
| 6.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7. Global Breast Cancer Screening Market, By Application, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 7.1. Screening |
| 7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Diagnostic and Predictive |
| 7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Prognostic |
| 7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Research |
| 7.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8. Global Breast Cancer Screening Market, By End User, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 8.1. Hospitals and Clinics |
| 8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Diagnostic Centers |
| 8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Academic and Research Institutes |
| 8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Others |
| 8.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 9. Global Breast Cancer Screening Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia-Pacific |
| 9.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Latin America |
| 9.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Middle East and Africa |
| 9.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 9.6. Global Breast Cancer Screening Market - Opportunity Analysis Index, By Component, By Technology, By Application, By End User, and Region, 2022-2028 |
| 10. North America Breast Cancer Screening Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 10.1. Component Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Reagents and Kits |
| 10.1.2. Instruments |
| 10.1.3. Software and Services |
| 10.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1. Imaging |
| 10.2.2. Biopsy |
| 10.2.3. Genomic Tests |
| 10.2.4. Blood Tests |
| 10.2.5. Others |
| 10.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. Screening |
| 10.3.2. Diagnostic and Predictive |
| 10.3.3. Prognostic |
| 10.3.4. Research |
| 10.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.4.1. Hospitals and Clinics |
| 10.4.2. Diagnostic Centers |
| 10.4.3. Academic and Reaserach Institutes |
| 10.4.4. Others |
| 10.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.5.1. USA |
| 10.5.2. Canada |
| 10.6. North America Breast Cancer Screening Market - Opportunity Analysis Index, By Component, By Technology, By Application, By End User, and Country, 2022-2028 |
| 10.7. North America Breast Cancer Screening Market Dynamics – Trends |
| 11. Europe Breast Cancer Screening Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 11.1. Component Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Reagents and Kits |
| 11.1.2. Instruments |
| 11.1.3. Software and Services |
| 11.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1. Imaging |
| 11.2.2. Biopsy |
| 11.2.3. Genomic Tests |
| 11.2.4. Blood Tests |
| 11.2.5. Others |
| 11.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. Screening |
| 11.3.2. Diagnostic and Predictive |
| 11.3.3. Prognostic |
| 11.3.4. Research |
| 11.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.4.1. Hospitals and Clinics |
| 11.4.2. Diagnostic Centers |
| 11.4.3. Academic and Reaserach Institutes |
| 11.4.4. Others |
| 11.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.5.1. Germany |
| 11.5.2. UK |
| 11.5.3. France |
| 11.5.4. Spain |
| 11.5.5. Italy |
| 11.5.6. Rest of Europe |
| 11.6. Europe Breast Cancer Screening Market - Opportunity Analysis Index, By Component, By Technology, By Application, By End User, and Country, 2022-2028 |
| 11.7. Europe Breast Cancer Screening Market Dynamics – Trends |
| 12. Asia-Pacific Breast Cancer Screening Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 12.1. Component Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Reagents and Kits |
| 12.1.2. Instruments |
| 12.1.3. Software and Services |
| 12.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1. Imaging |
| 12.2.2. Biopsy |
| 12.2.3. Genomic Tests |
| 12.2.4. Blood Tests |
| 12.2.5. Others |
| 12.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. Screening |
| 12.3.2. Diagnostic and Predictive |
| 12.3.3. Prognostic |
| 12.3.4. Research |
| 12.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.4.1. Hospitals and Clinics |
| 12.4.2. Diagnostic Centers |
| 12.4.3. Academic and Reaserach Institutes |
| 12.4.4. Others |
| 12.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.5.1. China |
| 12.5.2. India |
| 12.5.3. Japan |
| 12.5.4. ASEAN |
| 12.5.5. Australia & New Zealand |
| 12.5.6. Rest of Asia-Pacific |
| 12.6. Asia-Pacific Breast Cancer Screening Market - Opportunity Analysis Index, By Component, By Technology, By Application, By End User, and Country, 2022-2028 |
| 12.7. Asia-Pacific Breast Cancer Screening Market Dynamics – Trends |
| 13. Latin America Breast Cancer Screening Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 13.1. Component Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Reagents and Kits |
| 13.1.2. Instruments |
| 13.1.3. Software and Services |
| 13.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1. Imaging |
| 13.2.2. Biopsy |
| 13.2.3. Genomic Tests |
| 13.2.4. Blood Tests |
| 13.2.5. Others |
| 13.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.3.1. Screening |
| 13.3.2. Diagnostic and Predictive |
| 13.3.3. Prognostic |
| 13.3.4. Research |
| 13.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.4.1. Hospitals and Clinics |
| 13.4.2. Diagnostic Centers |
| 13.4.3. Academic and Reaserach Institutes |
| 13.4.4. Others |
| 13.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 13.5.1. Brazil |
| 13.5.2. Mexico |
| 13.5.3. Rest of Latin America |
| 13.6. Latin America Breast Cancer Screening Market - Opportunity Analysis Index, By Component, By Technology, By Application, By End User, and Country, 2022-2028 |
| 13.7. Latin America Breast Cancer Screening Market Dynamics – Trends |
| 14. Middle East and Africa Breast Cancer Screening Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 14.1. Component Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1. Reagents and Kits |
| 14.1.2. Instruments |
| 14.1.3. Software and Services |
| 14.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1. Imaging |
| 14.2.2. Biopsy |
| 14.2.3. Genomic Tests |
| 14.2.4. Blood Tests |
| 14.2.5. Others |
| 14.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.3.1. Screening |
| 14.3.2. Diagnostic and Predictive |
| 14.3.3. Prognostic |
| 14.3.4. Research |
| 14.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.4.1. Hospitals and Clinics |
| 14.4.2. Diagnostic Centers |
| 14.4.3. Academic and Reaserach Institutes |
| 14.4.4. Others |
| 14.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 14.5.1. Gulf Cooperation Council (GCC) Countries |
| 14.5.2. South Africa |
| 14.5.3. Rest of MEA |
| 14.6. MEA Breast Cancer Screening Market - Opportunity Analysis Index, By Component, By Technology, By Application, By End User, and Country, 2022-2028 |
| 14.7. MEA Breast Cancer Screening Market Dynamics – Trends |
| 15. Competition Landscape |
| 15.1. Strategic Dashboard of Top Market Players |
| 15.2. Company Profiles (Introduction, Financial Analysis, Key Components, Key Developments, Strategies, and SWOT Analysis) |
| 15.2.1. General Electric Company |
| 15.2.2. Siemens Healthineers AG |
| 15.2.3. BD |
| 15.2.4. Danaher |
| 15.2.5. F. Hoffmann-La Roche Ltd. |
| 15.2.6. Hologic Inc. |
| 15.2.7. Koninklijke Philips N.V. |
| 15.2.8. Myriad Genetics |
| 15.2.9. Oncocyte Corporation |
| 15.2.10. QIAGEN |
| 15.2.11. Syantra, Inc. |
| 15.2.12. Thermo Fisher Scientific Inc. |
| 16. Research Methodology |
| 17. Key Assumptions and Acronyms |
